2m 2m 2m 2m 2m 2m 2m
Aldeyra Therapeu (ALDX)
NASDAQ
$1.57+$0.03 (+2.14%)
Price as of Aug 03, 2026 7:40 AM EDT- $92.9MMarket Cap
- -67.98%1-Year Change
- BiotechnologyIndustry
Aldeyra Therapeu (ALDX)
$1.57+$0.03 (+2.14%)
ALDX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.54 | ||
Change | -$0.06 (-3.75%) | ||
Open | $1.62 | ||
High | $1.63 | ||
Low | $1.52 | ||
Previous Close | $1.60 | ||
Volume | 576,807 | ||
30-Day Average Volume | 1,457,815 | ||
1-Week Change | 1.32% | ||
1-Month Change | -27.70% | ||
1-Year Change | -67.98% | ||
3-Year Change | -81.02% | ||
5-Year Change | -82.70% | ||
Fundamentals | |||
Shares Outstanding | 60.3M | ||
Total Assets | $66.5M | ||
Market Cap | $92.9M | ||
Enterprise Value | $43.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$3.5M | ||
Free Cash Flow | -$5.1M | ||
EBIT | -$3.5M | ||
EBITDA | -$3.4M | ||
Net Working Capital | $41.9M | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | -13 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -26 | ||
PEG | -1 | ||
Price/Free Cash Flow | -18 | ||
Price/Operating Cash Flow | -18 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue